ArticleBMC neurology2016

Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.

Tjalf Ziemssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.